Alcon has inaugurated a new manufacturing plant in Singapore to...

Alcon has inaugurated a new manufacturing plant in Singapore to produce ophthalmic pharmaceutical products. Construction on this 330,000-square-foot facility, located in the Tuas Biomedical Park, began in 2009, and represents an investment of around S$200 million (€114.85m-$159.27m). The location was strategically chosen to be closer and able to respond quickly ...

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.